Loading...
Riverstone Holdings Limited
AP4.SI•SES
Healthcare
Medical - Instruments & Supplies
S$0.68
S$0.00(0.00%)
Riverstone Holdings Limited (AP4.SI) Financial Performance & Statements
Review Riverstone Holdings Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
17.28%
↑ 17.28%
Operating Income Growth
28.40%
↑ 28.40%
Net Income Growth
30.20%
↑ 30.20%
Operating Cash Flow Growth
23.25%
↑ 23.25%
Operating Margin
31.64%
↑ 31.64%
Gross Margin
34.84%
↑ 34.84%
Net Profit Margin
25.21%
↑ 25.21%
ROE
16.94%
↑ 16.94%
ROIC
19.97%
↑ 19.97%
Riverstone Holdings Limited (AP4.SI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Riverstone Holdings Limited stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $278.04M | $298.44M | $246.88M | $249.47M |
| Cost of Revenue | $188.26M | $194.82M | $147.66M | $152.002M |
| Gross Profit | $89.78M | $103.61M | $99.22M | $97.47M |
| Gross Profit Ratio | $0.32 | $0.35 | $0.40 | $0.39 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $12.77M | $13.61M | $13.54M | $14.23M |
| Operating Expenses | $5.20M | $13.20M | $7.22M | $5.73M |
| Total Costs & Expenses | $193.46M | $208.03M | $154.88M | $157.73M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $10000.00 | $9000.00 | $14000.00 | $14000.00 |
| Depreciation & Amortization | $17.05M | $16.01M | $15.91M | $15.93M |
| EBITDA | $101.63M | $106.42M | $101.22M | $96.83M |
| EBITDA Ratio | $0.37 | $0.36 | $0.41 | $0.39 |
| Operating Income | $84.58M | $90.41M | $92.005M | $91.74M |
| Operating Income Ratio | $0.30 | $0.30 | $0.37 | $0.37 |
| Other Income/Expenses (Net) | -$10000.00 | -$9000.00 | -$14000.00 | -$14000.00 |
| Income Before Tax | $84.57M | $90.40M | $91.99M | $91.72M |
| Income Before Tax Ratio | $0.30 | $0.30 | $0.37 | $0.37 |
| Income Tax Expense | $14.53M | $18.20M | $19.49M | $19.54M |
| Net Income | $70.04M | $72.20M | $72.50M | $72.19M |
| Net Income Ratio | $0.25 | $0.24 | $0.29 | $0.29 |
| EPS | $0.05 | $0.05 | $0.05 | $0.05 |
| Diluted EPS | $0.05 | $0.05 | $0.05 | $0.05 |
| Weighted Avg Shares Outstanding | $1.48B | $1.48B | $1.48B | $1.48B |
| Weighted Avg Shares Outstanding (Diluted) | $1.48B | $1.48B | $1.48B | $1.48B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan